Infographic | April 13, 2022

Preference Among Users – Small Molecule Drug Substance

Source: ISR Reports

In Q32021, ISR asked API outsourcers which CDMOs they are currently working with, and if the choice were entirely up to them, which CDMO would they prefer to use for all small molecule drug substance manufacturing. The data show that Cambrex, Patheon, Lonza, STA Pharma and Pfizer CentreOne are each the preferred CDMO among roughly one-third of their current customers. To learn more about CDMO preference among users, follow the link to the Small Molecule API CDMO Benchmarking report preview.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online